Cite
HARVARD Citation
Buckley, C. et al. (n.d.). OP0228 GSK3196165 AN INVESTIGATIONAL ANTI-GM-CSF MONOCLONAL ANTIBODY, IMPROVES PATIENT REPORTED OUTCOMES IN A PHASE IIB STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA). Annals of the rheumatic diseases. p. 191. [Online].